Accelerate Drug Discovery with Enterprise-Scale Bioinformatics
Power breakthroughs from discovery to market with scalable, compliant bioinformatics that unifies R&D, clinical, and regulatory teams
Request a DemoOvercoming Pharma R&D and Drug Discovery Challenges
With omics data and complex multi-modal analyses becoming more critical than ever to drug discovery, pharma companies face pressures that traditional approaches can't solve. Teams struggle with siloed systems, legacy data processes that bottleneck discovery timelines, and complex data orchestration across global infrastructure—all while meeting stringent regulatory requirements. Teams can now scale scientific workflows without compromising control, security, or reproducibility with Seqera.
Discovery & Development
- →Target identification
- →Protein structure prediction
- →AI-driven structure modeling
- →Compound design
- →Lead optimization
- →Structure-activity relationships
- →ADMET prediction
- →Agent-based modeling
Preclinical Research
- →Omics analysis
- →High-throughput screening
- →Biomarker discoviery
- →CRISPR screening
- →Biological imaging
- →Quantitative proteomics
- →Differential expression
- →Toxicology studies
Clinical Research
- →Variant calling analysis
- →Spatial omics profiling
- →Epitope prediction analysis
- →Diffusion MRI and medical imaging
- →Personalized medicines
- →Patient stratification
- →GxP for clinical trials
- →Vaccine development
Key Challenges We Address
Data Integration
Fragmented systems across research areas create bottlenecks and hinder collaboration across therapeutic programs.
Scalability
Compute-intensive workflows for cell therapy, gene therapy, and precision medicine require flexible, scalable infrastructure.
Regulatory Compliance
Ensuring full audit trails and data governance across global R&D operations while aligning with GxP, EU Annex 11, and 21 CFR Part 11 requirements.
R&D Bottlenecks
Scientists waiting for infrastructure provisioning and pipeline deployment slow down innovation cycles and time-to-insight.
How Seqera Powers Biopharma R&D
Trusted by 13 of the top 20 pharma companies, Seqera supports your entire drug development lifecycle from discovery through to clinical research and regulatory submissions. Our enterprise platform eliminates handoffs and accelerates scientific progress across every stage of therapeutic development.
- →Unified access to research and clinical datasets
- →Launch analyses faster with connected data
- →Seamless access across storage and teams
- →End-to-end traceability from raw data to results
Why Seqera for Pharma?
Seqera is the only platform backed by the creators of Nextflow, the gold standard for enterprise-scale bioinformatics. Used by 150+ pharma and biotech organizations worldwide, Seqera delivers unmatched expertise with enterprise-grade control. Deploy anywhere, scale seamlessly, and maintain full compliance across global sites.
Scale from Discovery to Global Operations
Full visibility and control from initial experimentation to production-scale execution within a single platform. Seqera reduces friction between scientists, informatics, and infrastructure teams while ensuring reproducibility across research and regulated production contexts.
Enterprise-Grade Governance
Robust controls with RBAC, audit logs, workspace isolation, and full traceability designed for regulated environments. Seqera enables enterprise governance across discovery, translational, and clinical programs without operational overhead.
Deploy Anywhere with Full Infrastructure Sovereignty
Run pipelines where your data lives—cloud, hybrid, or on-premises—without forced data migration or vendor lock-in. You maintain complete data residency and control while aligning with complex enterprise IT policies and GxP requirements.
Unified Data Lifecycle Platform
Orchestrate data pipelines and perform interactive analysis in-place across your organizations’ existing infrastructure without data movement. Seqera eliminates barriers between execution and analysis, reducing turnaround time and compliance risk across therapeutic programs.
Real-Time Collaboration for R&D Teams
Break down silos with secure, simultaneous access to shared, interactive analysis environments. Seqera enables faster, more transparent scientific decisions while empowering wet lab teams to work independently.
Future-Proofed Investment
Stay ahead of evolving therapeutic modalities and regulatory requirements with a modular platform built on open standards. Adapt to new analytical tools, compliance frameworks, and AI capabilities without costly migrations or system overhauls across your R&D portfolio.
Trusted by 13 of Top 20 Pharma Companies
Leading biopharmaceutical organizations trust Seqera to accelerate their most critical research programs. From precision medicine initiatives to supporting clinical trials, Seqera delivers the scalability, security, and scientific rigor that enterprise pharma demands.
"By streamlining our single-cell assay workflows with Seqera, we significantly improved operational efficiency by reducing execution time by 24%."
"After deploying Seqera, our researchers rapidly became
self-sufficient in launching and monitoring pipelines."
"Using Seqera helped us save time and resources. In addition to improving research productivity, our IT team’s workload has been reduced considerably."
